{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:26:36Z","timestamp":1783081596820,"version":"3.54.6"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1093\/jac\/dkx031","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T12:09:21Z","timestamp":1487592561000},"page":"i29-i38","source":"Crossref","is-referenced-by-count":15,"title":["Clinical considerations in the early treatment of invasive mould infections and disease"],"prefix":"10.1093","volume":"72","author":[{"given":"Toine","family":"Mercier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"key\n\t\t\t\t20170317082733_dkx031-B1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/517849","article-title":"Invasive aspergillosis in patients with acute leukemia: Update on morbidity and mortality\u2014SEIFEM-C report","volume":"44","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QCO.0000000000000043","article-title":"Approach to invasive pulmonary aspergillosis in critically ill patients","volume":"27","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B5","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/jac\/dkq442","article-title":"Managing invasive fungal infections: relying on clinical instincts or a rational navigation system?","volume":"66","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3324\/haematol.2012.061952","article-title":"The role of antifungal treatment in hematology","volume":"97","year":"2012","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B7","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","year":"2006","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B9","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","year":"2014","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B10","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B11","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2014-04-516211","article-title":"How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach","volume":"124","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B12","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/jac\/dks266","article-title":"Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B15","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.clinthera.2011.01.009","article-title":"Effectiveness of systemic antifungal prophylaxis in patients with neutropenia after chemotherapy: a meta-analysis of randomized controlled trials","volume":"32","year":"2010","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkt329","article-title":"Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B19","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"IMPROVIT Study Group","year":"2011","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B21","author":"European Society of Clinical Microbiology and Infectious Diseases\/European Fungal Infection Study Group"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/bmt.2009.259","article-title":"Fungal infection prevention after hematopoietic cell transplantation","volume":"44","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B24","author":"Food and Drug Administration Antiviral Drugs Advisory Committee","year":"2001"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2009.09.033","article-title":"Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole","volume":"62","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/tid.12367","article-title":"Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients","volume":"17","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.healun.2012.02.033","article-title":"High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients","volume":"31","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B28","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.healun.2012.05.003","article-title":"Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole","volume":"31","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1524-4725.2012.02418.x","article-title":"Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation","volume":"38","year":"2012","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B30","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B31","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B32","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.clinthera.2010.04.005","article-title":"Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis","volume":"32","year":"2010","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2011.051995","article-title":"Comparative clinical effectiveness of prophylactic voriconazole\/posaconazole to fluconazole\/itraconazole in patients with acute myeloid leukemia\/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period","volume":"97","year":"2012","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B35","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2008.06.040","article-title":"Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis","volume":"44","year":"2008","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9343(87)90949-1","article-title":"Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole","volume":"83","year":"1987","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10096-012-1794-4","article-title":"Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study","volume":"32","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":"A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia","volume":"29","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2011.049999","article-title":"Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach","volume":"97","year":"2012","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jcp.2008.058354","article-title":"Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients","volume":"62","year":"2009","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial","volume":"60","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B43","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/j.1439-0507.2010.01947.x","article-title":"Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC\/MSG 2008 definitions of invasive mould disease","volume":"54","year":"2011","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciu911","article-title":"Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group","volume":"60","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2015.03.021","article-title":"Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients","volume":"37","year":"2015","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2008.355","article-title":"A prospective, randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT","volume":"43","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial","volume":"13","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B50","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/AAC.00673-10","article-title":"The initial 96\u2009hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1\u21923) \u03b2-d-glucan and consequences of delayed antifungal therapy","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/JCM.03233-15","article-title":"Comparison of nonculture blood-based tests for diagnosing invasive aspergillosis in an animal model","volume":"54","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B54","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JCM.00906-15","article-title":"Analytical comparison of in vitro-spiked human serum and plasma for PCR-based detection of Aspergillus fumigatus DNA: a study by the European Aspergillus PCR Initiative","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B55","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B56","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/JCM.00744-13","article-title":"Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis","volume":"51","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B57","article-title":"Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology","volume":"61","year":"2012","journal-title":"J Vis Exp"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B58","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/CVI.00068-08","article-title":"Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis","volume":"15","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B59","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/JCM.02838-12","article-title":"Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study","volume":"51","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diagmicrobio.2012.01.012","article-title":"Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis","volume":"73","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170317082733_dkx031-B61","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00253-015-7209-6","article-title":"Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis","volume":"100","year":"2016","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/suppl_1\/i29\/11021781\/dkx031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T14:29:23Z","timestamp":1749997763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":61,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,3,17]]},"published-print":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx031","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}